Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS)

107 filings reported holding ACRS - Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q2 2019.
Aclaris Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ACRS) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 35,610,940 shares of 108,380,780 outstanding shares and own 33% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3,983,025 shares), FRANKLIN RESOURCES INC (3,845,423 shares), BlackRock Inc. (2,982,408 shares), Man Group plc (2,057,936 shares), Rock Springs Capital Management LP (2,028,000 shares), Sofinnova Investments, Inc. (1,911,573 shares), VANGUARD GROUP INC (1,867,838 shares), Vivo Capital, LLC (1,647,214 shares), Endurant Capital Management LP (1,629,327 shares), and MFN Partners Management, LP (1,500,000 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.